---
title: "Protokoll"
editor: 
  markdown: 
    wrap: 72
---

<p> </p>

## Version 1.2:

[Download the Protocol
(PDF)](files/RETUNE_Protocol_V1.2.pdf){target="_blank"}

<p> </p>

## Version 1.1:

[Download the Protocol
(PDF)](files/RETUNE_Protocol_V1.1.pdf){target="_blank"}

<p> </p>

## Protocol amendment history:

+------------------+---------------+----------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------+---------------+
| Protocol version | Protocol date | Description                                                                                                                      | Changes to prior version                                                                                                                                                                                                                                       | Status       | Approval date |
+==================+===============+==================================================================================================================================+================================================================================================================================================================================================================================================================+==============+===============+
| 1.0              | 28.11.2024    | Initial protocol submission to the ethics committee (Ethikkommission Nordwest- und Zentral Schweiz) in November 2024.            |                                                                                                                                                                                                                                                                | Not approved | 19.12.2025    |
+------------------+---------------+----------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------+---------------+
| 1.1              | 06.01.2025    | Adapted version after comments from the ethics committee. This was the finally approved version before the start of recruitment. | \-**Change of eligibility criteria:** Following the recommendation of the ethics committee, we changed the eligibility criteria and excluded pregnant women from the trial.                                                                                    | Approved     | 08.01.2025    |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Clarification on data collection:** We specified when RETUNE uses trial specific data collection and when routine cohort data collection.                                                                                                                  |              |               |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Clarification on participation in other research projects:** RETUNE participants are allowed to participate in other research while RETUNE participation.                                                                                                  |              |               |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Specification on the trial discontinuation:** Participants can discontinue intervention product use and will remain in the cohort.                                                                                                                         |              |               |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Addition of monitoring plan:** The monitoring procedure is outlined in chapter 9 of the revised protocol.                                                                                                                                                  |              |               |
+------------------+---------------+----------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------+---------------+
| 1.1              | 06.01.2025    | Addition of a new center, protocol version remains the same.                                                                     | \-**Addition of a new center:** The Cantonal Hospital St. Gallen and the University Hospital Zurich has been added as a participating center.                                                                                                                  | Approved     | 15.04.2025    |
+------------------+---------------+----------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------+---------------+
| 1.1              | 06.01.2025    | Addition of a new center, protocol version remains the same.                                                                     | **-Addition of a new center:** The University Hospital Bern has been added as a participating center.                                                                                                                                                          | Approved     | 07.05.2025    |
+------------------+---------------+----------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------+---------------+
| 1.1              | 06.01.2025    | Addition of a new center, protocol version remains the same.                                                                     | **-Addition of a new center:** The University Hospital Geneva has been added as a participating center.                                                                                                                                                        | Approved     | 09.07.2025    |
+------------------+---------------+----------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------+---------------+
| 1.1              | 06.01.2025    | Addition of a new center, protocol version remains the same.                                                                     | **-Addition of a new center:** The University Hospital Lausanne has been added as a participating center.                                                                                                                                                      | Approved     | 29.07.2025    |
+------------------+---------------+----------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------+---------------+
| 1.2              | 08.08.202     | Adapted version based on accumulated changes over the course of the trial.                                                       | \-**Addition of a new center:** The Cantonal Hospital Aarau has been added as a participating center.                                                                                                                                                          | Approved     | 24.09.2025    |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Removal of biochemical verification of smoking cessation:** The planned biochemical verification of patient-reported smoking abstinence using plasma anabasine as an explanatory endpoint has been removed.                                                |              |               |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Changes to secondary endpoints:** We have added measurement of total cholesterol in addition to HDL- and LDL-cholesterol. We have also removed death from the composite cardiovascular endpoint, as mortality will be captured as a serious adverse event. |              |               |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Additional methodological details:** We have added information on allocation concealment and blinding.                                                                                                                                                     |              |               |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Correction of primary estimand**: An error in the definition of the primary estimand has been corrected, and the description improved for clarity.                                                                                                         |              |               |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Statistical analysis updates:** We have added details on the conduct of subgroup analyses and the handling of missing data.                                                                                                                                |              |               |
|                  |               |                                                                                                                                  |                                                                                                                                                                                                                                                                |              |               |
|                  |               |                                                                                                                                  | \-**Addition of process evaluation:** We have included a paragraph describing the planned process evaluation study to better understand potential mechanisms of the intervention’s effect (or lack thereof).                                                   |              |               |
+------------------+---------------+----------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------+---------------+

# 
